製品名
FITC Conjugated CD15 Recombinant Rabbit Monoclonal Antibody [PD00-42]
抗体のタイプ
Recombinant Rabbit monoclonal Antibody
標的分子量
Predicted band size: 59 kDa
保存方法
Store at 2-8℃. Avoid freeze.
保存バッファー
Supplied in phosphate-buffered solution, pH 7.2, containing 0.2% ProClean 950 and BSA.
精製方法
Protein A affinity purified.
機能
CD15 is a complex cluster of cell surface glycoproteins and glycolipids having a common terminal pentasaccaharide known as the Lewisx (Lex) antigen. CD15 is a haemopoietic differentiation antigen expressed on most terminally differentiated myeloid cells including granulocytes, eosinophils, mast cells, monocytes/macrophages, and Langerhans' cells. CD15 is not substantially expressed on haemopoietic progenitor cells. The positivity for CD15 is characteristic of Hodgkin’s cells in classical Hodgkin’s disease (HD). Rare cases of acute lymphoblastic leukaemia, in which myeloid antigens are often CD15 positive. Myeloid leukaemia cells express CD15 in a heterogeneous manner. CMLs are regularly CD15 positive. CD15 is expressed in a varying proportion of epithelial tumours such as adenocarcinomas (particularly from breast, lung and colon), renal cell carcinoma, apocrine carcinoma of the skin, papillary and follicular carcinoma of the thyroid, and serous carcinoma of the ovary. It is possible that sialyl-CD15 confer on the tumour cells the capacity to metastasize. Malignant mesothelioma is practically always CD15 negative (positivity has been reported in up to 6%, particularly the desmoplastic variant). In gliomas, CD15 positivity inversely correlates with the grade of malignancy. Among germ cell tumours, CD15 is detected only in mature teratoma. In haematopathology CD15 is important for the diagnosis of classical HD and characterization of acute leukaemia. CD15 may be used for histopathological grading of gliomas and differentiating between malignant gliomas and non-neoplastic glial cells (the latter usually strongly stained). Kidney and tonsil are recommended as positive and negative tissue controls for CD15.
背景・参考文献
1. Seidmann L et al. CD15 immunostaining improves placental diagnosis of fetal hypoxia. Placenta. 2021 Feb
2. Tian X et al. Circulating CD15+ LOX-1+ PMN-MDSCs are a potential biomarker for the early diagnosis of non-small-cell lung cancer. Int J Clin Pract. 2021 Aug
サブセルラー局在
Golgi apparatus, Golgi stack membrane
別名
3 fucosyl N acetyl lactosamine antibody
3-FAL antibody
3-fucosyl-N-acetyl-lactosamine antibody
Leu M1 antibody
Lewis X antibody
LeX antibody
SSEA-1 antibody
stage-specific embryonic antigen 1 antibody
-
Flow cytometric analysis of human peripheral blood labelling CD15 (HA720195F, FITC).
ご注意: 本製品はすべて「研究用試薬」です。人や動物の診断・治療目的、または臨床診断には使用できません。(FOR RESEARCH USE ONLY)